ACHE and early-onset autosomal dominant Alzheimer disease: The urgent need for new drugs to treat cholinergic disorders like Alzheimer's disease [14], and the limited applicability of the currently available antidotes to nerve agent intoxications (in terms of blood-brain barrier permeability [15] and spectrum [16]) make the research for new AChE inhibitors highly relevant.